Mersana Therapeutics Inc.

0.32
-0.03 (-8.18%)
At close: Apr 16, 2025, 3:09 PM

Mersana Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-69.19M -171.67M -204.21M -170.06M -88.05M -28.21M -64.26M -38.71M -13.7M
1.63M 1.52M 927K 855K 1.01M 1.25M 1.26M 928K 655K
16.46M 21.14M 21.52M 18.41M 7.17M 4.87M 3.88M 1.42M 668K
-27.88M -42.68M 162.15M 9.6M 4.16M -41.38M -6.13M -10.05M 43.28M
-496K -1.1M -699K 723K 148K 103K 110K -159K 102K
n/a n/a n/a n/a -86K -222K -386K -134K -102K
-30.74M -18.76M 133.1M 10.09M 5.11M -45.53M 4.18M -6.03M 43.97M
-82.34M -168.88M -49.36M -139.99M -74.7M -67.74M -55.22M -42.68M 31.59M
-132K -2.17M -2.2M -648K -473K -605K -1.37M -1.14M -1.08M
n/a n/a 150.52M n/a n/a 26.69M n/a n/a n/a
-133.43M -155.92M -247.52M n/a n/a -53.69M n/a -145.7M n/a
145M 277.97M 97M n/a 37.5M 27M 88.56M 47.22M n/a
n/a n/a -150.52M n/a 37.5M -26.69M 88.56M -98.48M n/a
11.44M 119.88M -152.72M -648K 37.03M -27.29M 87.19M -99.62M -1.08M
-2.23M -262K -272K 18.34M -116K 4.88M n/a n/a n/a
n/a n/a n/a n/a n/a n/a 146K n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a n/a
542K 1.4M 2.4M 2.22M 3.5M 664K 1.06M 452K 105K
4.09M 94.67M 153.02M 63.65M 230.41M 97.7M 1.06M 68.6M 58.26M
-66.81M 45.68M -49.06M -76.99M 192.74M 2.67M 33.04M -73.71M 88.76M
-82.47M -171.05M -51.56M -140.64M -75.17M -68.35M -56.59M -43.82M 30.5M